Only one TP53 mutation was detected in the tumor tissue of the 19 IEM‐AML episodes at a limit of detection of 5%, despite four different patients presenting with a complex karyotype at the initial diagnosis. The gene discussed is TP53; the disease is acute myeloid leukemia.